Environmental exposure: Susceptibility alleles in a DNA damage response pathway
Environmental exposure: Susceptibility alleles in a DNA damage response pathway
批准号:
7575486
负责人:
PETER J. STAMBROOK
金额:
$47.78万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-12-01 至 2013-11-30
关键词:
Adverse effectsAffectAllelesAntioxidantsBRCA1 geneBRCA2 geneBenignCHEK2 geneCell CycleCell Cycle CheckpointCellsCharacteristicsChildDNADNA DamageDNA Double Strand BreakDNA RepairDataDiseaseDisease ProgressionDisease susceptibilityDoseEnvironmental ExposureExposure toGenesGenetic VariationGenome StabilityGenomic InstabilityGenotypeHodgkin DiseaseHumanHypersensitivityIndividualIonizing radiationKnockout MiceLifeLow Dose RadiationMalignant NeoplasmsMeasurableMeasuresMediatingMitotic RecombinationModelingMusMutagenesisMutationNeoplasm MetastasisOutcomeOxidative StressPLK3 genePathway interactionsPatientsPenetrancePhenotypePhosphoric Monoester HydrolasesPhosphotransferasesPlantsPopulationPopulation ControlPredispositionProcessProteinsRadiationRecording of previous eventsResistanceResourcesRiskSignal PathwaySignal TransductionTestingUraniumVariantWomanWorkataxia telangiectasia mutated proteincell injurychemotherapycigarette smokingcohortdisorder riskexperiencehuman PLK1 proteinhuman diseasemalignant breast neoplasmmembermouse modelpreventprogramspublic health relevancerepairedresponsetumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): When DNA is damaged, cells initiate a signaling cascade that results in cell cycle checkpoint arrest and repair of the damage or elimination of the damaged cells. One pathway that is activated following a double strand DNA break involves ATM and other DNA damage response proteins including CHEK2, Cdc25A, Plk3, BRCA1 and BRCA2. Several genes in this pathway, which contribute to genomic stability, have variant alleles that predispose to disease. This study focuses on mouse models and human cohorts who have had prior radiation exposure. The hypothesis is that variant alleles within the DNA damage response pathway may be benign or produce a modest risk, but that their adverse effects manifest more profoundly after exposure. One mouse model mimicks a CHEK2 variant that predisposes to breast cancer. Mice homozygous and heterozygous for this allele will be assessed for their inherent DNA repair capacity and whether they are more susceptible to disease and to mutagenesis, particularly to mitotic recombination and LOH before and after exposure. Other mouse models with deficiencies or variants in Plk3, BRCA2, and Cdc25A, have been made or are under construction. Additional models, dictated by the outcome of the human studies, will be produced. The human studies will utilize two unique cohorts with prior environmental exposure in the form of radiation who subsequently developed breast cancer. A control population consists of individuals who have experienced similar exposure but have not developed disease. The first cohort consists of patients who as children were treated with radiation for Hodgkin disease and years later developed breast cancer. The second cohort involves patients who worked at or lived in close proximity to the Fernald Uranium processing plant and have developed breast cancer. Specifically, we will ask whether variant alleles within the DNA damage response pathway, singly or in combination, are overrepresented in the affected population. When such alleles are identified, they will be modeled and tested in the mouse. Lastly, cells from affected individuals will be tested for genomic instability. In brief, this project assesses allelic variants within a pathway in two unique exposed populations and models the genotypes in mice. Since this pathway responds to damage induced by oxidative stress and since these alleles may sensitize to oxidative stress, the capacity of antioxidants to prevent disease in mouse models carrying variant alleles will be tested. PUBLIC HEALTH RELEVANCE: This project seeks to define genetic changes in a signaling pathway that contribute to susceptibility to breast cancer following environmental exposure. The program utilizes genetically modified mice that harbor variant genes that mimic gene variants found in human populations and that contribute to cancer. We will also ask whether such variants are over-represented in women who have had defined radiation exposure and now have developed breast cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathways to Mutagenesis in vivo and in Stem Cells
-
批准号:7916980
-
项目类别:
-
资助金额:$15.15万
-
财政年份:2009
-
负责人:PETER J. STAMBROOK
-
依托单位:
Environmental exposure: Susceptibility alleles in a DNA damage response pathway
-
批准号:8215811
-
项目类别:
-
资助金额:$50.13万
-
财政年份:2008
-
负责人:PETER J. STAMBROOK
-
依托单位:
Environmental exposure: Susceptibility alleles in a DNA damage response pathway
-
批准号:8391760
-
项目类别:
-
资助金额:$47.92万
-
财政年份:2008
-
负责人:PETER J. STAMBROOK
-
依托单位:
Environmental exposure: Susceptibility alleles in a DNA damage response pathway
-
批准号:8020143
-
项目类别:
-
资助金额:$50.17万
-
财政年份:2008
-
负责人:PETER J. STAMBROOK
-
依托单位:
Environmental Mutagen Society 38th Annual Meeting
-
批准号:7404979
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2007
-
负责人:PETER J. STAMBROOK
-
依托单位:
Pathways to Mutagenesis in vivo and in Stem Cells
-
批准号:7148780
-
项目类别:
-
资助金额:$38.77万
-
财政年份:2006
-
负责人:PETER J. STAMBROOK
-
依托单位:
Pathways to Mutagenesis in vivo and in Stem Cells
-
批准号:7644010
-
项目类别:
-
资助金额:$36.53万
-
财政年份:2006
-
负责人:PETER J. STAMBROOK
-
依托单位:
Pathways to Mutagenesis in vivo and in Stem Cells
-
批准号:7274874
-
项目类别:
-
资助金额:$37.67万
-
财政年份:2006
-
负责人:PETER J. STAMBROOK
-
依托单位:
Training Program in Cancer Therapeutics
-
批准号:7280437
-
项目类别:
-
资助金额:$39.17万
-
财政年份:2006
-
负责人:PETER J. STAMBROOK
-
依托单位:
Pathways to Mutagenesis in vivo and in Stem Cells
-
批准号:7454254
-
项目类别:
-
资助金额:$36.93万
-
财政年份:2006
-
负责人:PETER J. STAMBROOK
-
依托单位:
Student and Postdoctoral Level Investigator Travel Awards at 2005 EMS Meeting
-
批准号:7164485
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2006
-
负责人:PETER J. STAMBROOK
-
依托单位:
PPK: Radiation Response and Cell Proliferation
-
批准号:6696754
-
项目类别:
-
资助金额:$30.64万
-
财政年份:2002
-
负责人:PETER J. STAMBROOK
-
依托单位:
Plk3 variants in transgenic mice and MEFs
-
批准号:6617335
-
项目类别:
-
资助金额:$19.7万
-
财政年份:2002
-
负责人:PETER J. STAMBROOK
-
依托单位:
PPK: Radiation Response and Cell Proliferation
-
批准号:6621659
-
项目类别:
-
资助金额:$30.64万
-
财政年份:2002
-
负责人:PETER J. STAMBROOK
-
依托单位:
Plk3 variants in transgenic mice and MEFs
-
批准号:6579917
-
项目类别:
-
资助金额:$19.7万
-
财政年份:2002
-
负责人:PETER J. STAMBROOK
-
依托单位:
Plk3 variants in transgenic mice and MEFs
-
批准号:6618916
-
项目类别:
-
资助金额:$19.7万
-
财政年份:2002
-
负责人:PETER J. STAMBROOK
-
依托单位:
PPK: Radiation Response and Cell Proliferation
-
批准号:6987875
-
项目类别:
-
资助金额:$29.92万
-
财政年份:2002
-
负责人:PETER J. STAMBROOK
-
依托单位:
PPK: Radiation Response and Cell Proliferation
-
批准号:6836529
-
项目类别:
-
资助金额:$30.64万
-
财政年份:2002
-
负责人:PETER J. STAMBROOK
-
依托单位:
PPK: Radiation Response and Cell Proliferation
-
批准号:6435586
-
项目类别:
-
资助金额:$30.64万
-
财政年份:2002
-
负责人:PETER J. STAMBROOK
-
依托单位:
Comparative Mouse Genomics Centers Consortiun
-
批准号:6825883
-
项目类别:
-
资助金额:$1.08万
-
财政年份:2001
-
负责人:PETER J. STAMBROOK
-
依托单位:
海外基金